Trivascular Technologies Inc (TRIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||
| Net Income | -57,373 | -50,308 | -43,312 |
| Depreciation Amortization | 1,235 | 1,479 | 2,796 |
| Accounts receivable | -2,143 | -3,033 | 113 |
| Accounts payable and accrued liabilities | 184 | 462 | 216 |
| Other Working Capital | -2,317 | -573 | -1,051 |
| Other Operating Activity | 6,832 | 5,057 | 7,281 |
| Operating Cash Flow | $-53,582 | $-46,916 | $-33,957 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -46,128 | N/A | 1,005 |
| PPE Investments | -273 | -221 | -175 |
| Other Investing Activity | 0 | 13 | 21 |
| Investing Cash Flow | $-46,401 | $-208 | $851 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 15,723 | N/A | 50,108 |
| Debt Repayment | -4,599 | N/A | -24,055 |
| Common Stock Issued | 83,732 | 59 | 564 |
| Other Financing Activity | 0 | 39,772 | 48,650 |
| Financing Cash Flow | $94,856 | $39,831 | $75,267 |
| Exchange Rate Effect | -85 | 8 | -9 |
| Beginning Cash Position | 38,108 | 45,393 | 3,241 |
| End Cash Position | 32,896 | 38,108 | 45,393 |
| Net Cash Flow | $-5,212 | $-7,285 | $42,152 |
| Free Cash Flow | |||
| Operating Cash Flow | -53,582 | -46,916 | -33,957 |
| Capital Expenditure | -273 | -221 | -175 |
| Free Cash Flow | -53,855 | -47,137 | -34,132 |